CompoAtlas

Solace

Solace, licence 80079587: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
CHIPMAN HEALTH
NPN or DIN-HM
80079587
Status
Active licence
Licence date
21 August 2017
Revision date
18 February 2021
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Acide hyaluronique

Source : Gallus gallus - Crête

100.0 milligrammeNot calculated
3,3'-dihydroxy-4,4'-diketo-bêta-carotène

Source : Astaxanthin

4.0 milligrammeNot calculated
Lutéine

Source : Lutéine

10.0 milligrammeNot calculated
(3R,3'R)-bêta,bêta-Carotène-3,3'-diol

Source : Arnica Montana - fleur

1.0 milligrammeNot calculated

Non-medicinal ingredients

Gélatine

PopulationAgeQuantity per servingFrequency
AdultesNot specified1.0 Capsule2.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Provides antioxidants for the maintenance of eye health. Helps to maintain eyesight in conditions (associated with sunlight damage) such as cataracts and age related macular degeneration. Help to improve macular pigment optical density. Provide antioxidants for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80079587

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2021. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line